Tenaya Therapeutics, Inc. ($TNYA)
Filing Information
| Accession Number | 0001193125-26-039763 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
367,250
Total Value
$0.00
P&L
+inf% (+$314,880.15)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 3, 2026 | Grant/Award | 48,750 | $0.00 | $0.00 | 223,778 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to buy) | Derivative | Feb 3, 2026 | Grant/Award | 318,500 | $0.00 | $0.00 | 318,500 | Direct | โ | View Details |